Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
687
datasets available to search
ShareScore release 0.9.0
Dataset results
687 results for “MDS”
Oral Arsenic (ATO) in Low-risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT06670222. IPD Sharing: NO. Countries: 1. Publications: 0.
ED-TBI Followed By Allogeneic Stem Cell Transplantation For The Treatment Of Refractory AML And Advanced MDS
ClinicalTrials.gov study NCT01709396. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Quality of Life-Guided Transfusion in Refractory MDS or AML
ClinicalTrials.gov study NCT07328191. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical and Genomic Registry of MDS in Asia
ClinicalTrials.gov study NCT03169296. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients
ClinicalTrials.gov study NCT02550535. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Safety and Efficacy of IBI188 With Azacitidine in Subjects With Newly Diagnosed Higher Risk MDS
ClinicalTrials.gov study NCT04485065. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Study of BC3402 as a Single Agent in Patients With MDS and CMML
ClinicalTrials.gov study NCT05690425. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Trial of Omacetaxine, Azacitidine, and Growth-Colony Stimulating Factor (G-CSF) for Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT02835794. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Intensified Azacitidine in High Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01305460. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS
ClinicalTrials.gov study NCT01085656. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS.
ClinicalTrials.gov study NCT04275518. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT03886662. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Unrelated Umbilical Cord Blood Stem Cell Combined With Azacitidine Based Treatment for Advanced MDS,CMML-2 and sAML
ClinicalTrials.gov study NCT05584761. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase Ib Study of Select Drug Combinations in Patients With Lower Risk MDS
ClinicalTrials.gov study NCT04810611. IPD Sharing: NO. Countries: 7. Publications: 0.
Influence of Exercise on Anemia in MDS Patients
ClinicalTrials.gov study NCT01783249. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS
ClinicalTrials.gov study NCT04749355. IPD Sharing: NO. Countries: 1. Publications: 0.
Monitoring Mutational Burden in Low Risk MDS Patients Using Sequential Peripheral Blood Samples
ClinicalTrials.gov study NCT04251078. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients
ClinicalTrials.gov study NCT04587856. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Safety and Efficacy Study of LGH447 in Patients With Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02078609. IPD Sharing: NO. Countries: 7. Publications: 0.
Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00402558. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.